行情

AMPH

AMPH

Amphastar制药
NASDAQ

实时行情|Nasdaq Last Sale

14.78
+0.01
+0.07%
盘后 16:12 04/03 EDT
开盘
14.64
昨收
14.77
最高
14.96
最低
14.22
成交量
22.06万
成交额
--
52周最高
23.06
52周最低
12.33
市值
6.83亿
市盈率(TTM)
15.09
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AMPH价格均价为21.75,最高价位24.00,最低价为20.00。

EPS

AMPH 新闻

更多
  • Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
  • Thomson Reuters StreetEvents · 4天前
  • Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pay Justified?
  • Simply Wall St. · 6天前
  • Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
  • Zacks · 03/25 14:33
  • What Bargain Hunting? Tap 5 Stocks With Rising P/E
  • Zacks · 03/24 14:47

所属板块

制药
-0.14%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

AMPH 简况

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.
展开

微牛提供Amphastar Pharmaceuticals Inc(NASDAQ-AMPH)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AMPH股票新闻,以帮助您做出投资决策。